1. Home
  2. FEIM vs AFMD Comparison

FEIM vs AFMD Comparison

Compare FEIM & AFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEIM
  • AFMD
  • Stock Information
  • Founded
  • FEIM 1961
  • AFMD 2000
  • Country
  • FEIM United States
  • AFMD Germany
  • Employees
  • FEIM N/A
  • AFMD N/A
  • Industry
  • FEIM Electrical Products
  • AFMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEIM Industrials
  • AFMD Health Care
  • Exchange
  • FEIM Nasdaq
  • AFMD Nasdaq
  • Market Cap
  • FEIM 119.5M
  • AFMD 53.3M
  • IPO Year
  • FEIM N/A
  • AFMD 2014
  • Fundamental
  • Price
  • FEIM $12.80
  • AFMD $3.36
  • Analyst Decision
  • FEIM
  • AFMD Strong Buy
  • Analyst Count
  • FEIM 0
  • AFMD 5
  • Target Price
  • FEIM N/A
  • AFMD $16.25
  • AVG Volume (30 Days)
  • FEIM 19.0K
  • AFMD 80.0K
  • Earning Date
  • FEIM 12-10-2024
  • AFMD 11-12-2024
  • Dividend Yield
  • FEIM 7.98%
  • AFMD N/A
  • EPS Growth
  • FEIM N/A
  • AFMD N/A
  • EPS
  • FEIM 0.62
  • AFMD N/A
  • Revenue
  • FEIM $57,943,000.00
  • AFMD $7,959,927.00
  • Revenue This Year
  • FEIM N/A
  • AFMD N/A
  • Revenue Next Year
  • FEIM N/A
  • AFMD $48.98
  • P/E Ratio
  • FEIM $20.24
  • AFMD N/A
  • Revenue Growth
  • FEIM 28.82
  • AFMD N/A
  • 52 Week Low
  • FEIM $7.20
  • AFMD $2.92
  • 52 Week High
  • FEIM $14.50
  • AFMD $8.95
  • Technical
  • Relative Strength Index (RSI)
  • FEIM 52.77
  • AFMD 44.84
  • Support Level
  • FEIM $12.17
  • AFMD $3.28
  • Resistance Level
  • FEIM $12.72
  • AFMD $3.51
  • Average True Range (ATR)
  • FEIM 0.37
  • AFMD 0.17
  • MACD
  • FEIM 0.01
  • AFMD 0.04
  • Stochastic Oscillator
  • FEIM 45.37
  • AFMD 55.79

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

Share on Social Networks: